Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema
NCT01042678
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
18
Enrollment
INDUSTRY
Sponsor class
Stopped
The study was terminated due to a company decision.
Conditions
Diabetic Macular Edema
Interventions
BIOLOGICAL:
MP0112
Sponsor
Allergan
Collaborators
[object Object]